Eastwood Bio-Medical Canada Inc. announced earnings results for the second quarter ended April 30, 2021. For the second quarter, the company announced total revenue was CAD 285,879 compared to CAD 193,662 a year ago. Net loss was CAD 230,495 compared to CAD 258,857 a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago. For the half year, total revenue was CAD 485,128 compared to CAD 330,443 a year ago. Net loss was CAD 422,055 compared to CAD 502,799 a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.